Viewing nowCanarb 120 mg (Pimasartan Potassium Trihydrate)
Fimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

MFDS item code 201005500 · Approved 2010.09.09 · Insurance code 641905460
Essential hypertension; reduction of proteinuria in hypertensive patients with diabetic chronic kidney disease
This medication helps effectively lower blood pressure in patients with essential hypertension. It is also used to reduce proteinuria in patients with essential hypertension and chronic kidney disease associated with type 2 diabetes. This contributes to preventing deterioration of kidney function and improving overall health status. Therefore, this medication is effective in improving complications related to hypertension and protecting the kidneys.
1. Essential hypertension Adults The recommended dose of this medicine is 30 ~ 60 milligrams once daily, regardless of meals. If blood pressure is not adequately controlled at this dose, it may be increased to 120 milligrams once daily. If possible, it is recommended that the medicine be taken at the same time each day (e.g., in the morning). The blood pressure-lowering effect appears within 2 weeks of starting treatment, with the maximum effect reached after approximately 8 weeks ~ 12 weeks. Elderly patients No adjustment of the initial dose is necessary for elderly patients 70 years of age or younger. For elderly patients over 70 years of age, the recommended initial dose is 30 mg of this medicine once daily. (See section 9. Administration to elderly patients under Precautions for Use.) Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment (creatinine clearance 30 ~ 80 mL/min). For patients with severe renal impairment (creatinine clearance < 30 mL/min), start treatment with 30 milligrams once daily and do not exceed 60 milligrams per day. Patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment. Do not administer this medicine to patients with moderate ~ severe hepatic impairment (see sections 2. Patients Who Should Not Receive This Medicine and 10. Administration to Patients with Hepatic Impairment under Precautions for Use). Patients with decreased effective intravascular volume (e.g., patients taking high doses of diuretics) For patients at high risk of hypotension, such as those with decreased effective intravascular volume, an initial dose of 30 milligrams once daily is recommended. (See section 3. Patients Who Should Be Treated with Caution under Precautions for Use.) 2. Reduction of proteinuria in patients with hypertensive type 2 diabetic chronic kidney disease as a treatment for hypertension The usual dose is 60 milligrams of this medicine once daily, regardless of meals. The dose may be increased to 120 milligrams once daily depending on blood pressure. However, an initial dose of 30 milligrams is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered in combination with antidiabetic agents.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients 18 years of age or younger.
This medication can cause serious harm or death to the fetus or newborn if taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately upon confirmation of pregnancy. Patients who are allergic to any ingredients in this medication or are pregnant or breastfeeding, patients undergoing renal dialysis, those with severe liver impairment, patients with bile duct obstruction, and diabetic patients with certain kidney diseases should not take this medication. Patients with low blood volume or sodium, impaired kidney function, renal artery hypertension, problems with the aorta or heart valves, primary aldosteronism, and patients allergic to any dye contained in this drug should use it with caution. This medication may cause various side effects, including headaches, dizziness, dyspepsia, muscle stiffness, itching, erectile dysfunction, and rarely serious kidney problems, blood pressure abnormalities, liver function issues, etc. There may be symptoms of hypotension at the beginning of treatment or when the dosage is increased, so blood pressure and electrolyte levels should be monitored regularly, especially in patients on high-dose diuretics. There is a risk of elevated potassium levels, so patients with heart failure or kidney disease should have their serum potassium levels checked regularly. Drug interactions may occur when used with other antihypertensives, potassium-sparing diuretics, lithium, non-steroidal anti-inflammatory drugs, etc., so it is essential to consult a doctor or pharmacist if taking other medications. This medication is not recommended for breastfeeding women, and its safety for children and adolescents under 18 has not been established. Generally, elderly patients do not need dosage adjustments; however, some elderly patients may be more sensitive to the medication, requiring caution. Patients with severe liver impairment should not take this medication, and in case of overdose, symptoms such as hypotension or cardiac abnormalities may occur, requiring immediate medical assistance. This medication should be kept out of reach of children, and transferring it to other containers should be avoided due to the risk of quality degradation or accidents.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light and should be stored in special containers that block light. Additionally, it is advisable to store the medication at room temperature, between 1 and 30 degrees Celsius. Storing it this way helps to safely maintain the drug's effectiveness.
A pale orange, convex film-coated tablet in a hexagonal shape with a dividing line on one side and rounded corners.
30 tablets/bottle, 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowFimasartan Potassium Trihydrate 132.02mg
Tablet · Prescription medication
Boryung Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Boryung Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Aliko Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 66.01mg
Tablet · Prescription medication
Korea Hyutex Pharmaceuticals Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
HanKook Hytex Pharmaceutical Co., Ltd.

Fimasartan Potassium Trihydrate 33.005mg
Tablet · Prescription medication
Dongkuk Pharm Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.